MRI with Gadolinium-Based Nanoparticles - Nanotechnology for Biomedical Imaging and Diagnostics - page 246

[53] Kellar Ke, Henrichs pM, Hollister R, Koenig sH, eck J, Wei d. High relaxivity linear
Gd (dTpA)-polymer conjugates: the role of hydrophobic interactions. Magn Reson Med
1997; 38 :712-716.
[54] Allen MJ, Raines RT, Kiessling LL. Contrast agents for magnetic resonance imaging
synthesized with ring-opening metathesis polymerization. J Am Chem soc 2006; 128 :
6534-6535.
[55] Ladd dL, Hollister R, peng X, Wei d, Wu G, delecki d, snow RA, Toner JL, Kellar K,
eck J, desai VC, Raymond G, Kinter LB, desser Ts, Rubin dL. polymeric gadolinium
chelate magnetic resonance imaging contrast agents: design, synthesis, and properties.
Bioconjug Chem 1999; 10 :361-370.
[56] Ogan Md, schmiedl u, Moseley Me, Grodd W, paajanen H, Brasch RC. Albumin labeled
with Gd-dTpA: an intravascular contrast-enhancing agent for magnetic resonance blood
pool imaging: preparation and characterization. Invest Radiol 1987; 22 :665-671.
[57] pashkunova-Martic I, Kremser C, Galanski M, schluga p, Arion V, debbage p, Jaschke
W, Keppler B. Lectin conjugates as biospecific contrast agents for MRI. Coupling of
lycopersicon esculentum agglutinin to linear water-soluble dTpA-loaded oligomers.
Mol Imaging Biol 2011; 13 :432-442.
[58] shreve p, Aisen AM. Monoclonal antibodies labeled with polymeric paramagnetic ion
chelates. Magn Reson Med 1986; 3 :336-340.
[59] GÖhr-Rosenthal s, schmitt-Willich H, ebert W, Conrad J. The demonstration of human
tumors on nude mice using gadolinium-labelled monoclonal antibodies for magnetic
resonance imaging. Invest Radiol 1993; 28 :789-795.
[60] Yan G-p, Liu M-L, Li LY. polyaspartamide gadolinium complexes containing sulfadi-
azine groups as potential macromolecular MRI contrast agents. Bioconjug Chem
2005; 16 :967-971.
[61] Tachibana Y, enmi J-i, Mahara A, Iida H, Yamaoka T. design and characterization of a
polymeric MRI contrast agent based on pVA for in vivo living-cell tracking. Contrast
Media Mol Imaging 2010; 5 :309-317.
[62] Zarabi B, nan A, Zhuo J, Gullapalli R, Ghandehari H. Macrophage targeted
n-(2-Hydroxypropyl)methacrylamide conjugates for magnetic resonance imaging. Mol
pharm 2006; 3 :550-557.
[63] Zarabi B, Borgman M, Zhuo J, Gullapalli R, Ghandehari H. noninvasive monitoring of
HpMA copolymer-RGdfK conjugates by magnetic resonance imaging. pharm Res
2009; 26 :1121-1129.
[64] Aime s, Botta M, Frullano L, Crich sG, Giovenzana GB, pagliarin R, palmisano G, sisti
M. Contrast agents for magnetic resonance imaging: a novel route to enhanced relaxivi-
ties based on the interaction of a GdIII chelate with poly-β-cyclodextrins. Chem eur J
1999; 5 :1253-1260.
[65] Bogdanov A, Mazzanti ML. Molecular magnetic resonance contrast agents for the detec-
tion of cancer: past and present. semin Oncol 2011; 38 :42-54.
[66] Lu Z-R, Wang X, parker dL, Goodrich KC, Buswell HR. poly(l-glutamic acid) Gd(III)-
dOTA conjugate with a degradable spacer for magnetic resonance imaging. Bioconjug
Chem 2003; 14 :715-719.
[67] Mohs AM, Wang X, Goodrich KC, Zong Y, parker dL, Lu Z-R. peG-g-poly(GddTpA-
co-l-cystine): a biodegradable macromolecular blood pool contrast agent for mr imaging.
Bioconjug Chem 2004; 15 :1424-1430.